Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C

Virology Journal

Volumn 7, Issue , 2010, Pages

  Sedẽo Monge, Virginia ^a,b,d   Santos Lápez, Gerardo ^a   Rocha Gracia, Rosa C ^b   Meléndez Mena, Daniel ^c   Ramírez Mata, Alberto ^a   Vallejo Ruiz, Veránica ^a   Reyes Leyva, Julio ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d Universidad Popular Autnoma Del Estado de Puebla   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; PEGINTERFERON ALPHA; PROTEIN SUBUNIT; RIBAVIRIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; ALPHA BETA INTERFERON RECEPTOR; ALPHA2A INTERFERON; ANTIVIRUS AGENT; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADULT; AGED; ARTICLE; BLOOD CELL; DISEASE COURSE; FEMALE; GENETIC TRANSCRIPTION; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; VIRUS GENE; VIRUS LOAD; BIOSYNTHESIS; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTOR, INTERFERON ALPHA-BETA; RIBAVIRIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 77956585257     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-243     Document Type: Article

References (31)

1. Global burden of disease (GBD) for hepatitis C. Anon, J Clin Pharmacol 2004 44 20 29 10.1177/0091270003258669 14681338
2. Seroprevalencia de la hepatitis C en adultos de México: un problema de salud pblica emergente? JL Valdespino JC Conde-Gonzlez FG Olaiz O Palma D Kershenobich J Sepulveda, Salud Publica Mex 2007 49 395 S403
3. NIH Consensus Statement on Management of Hepatitis C: 2002. Anon, NIH Consens State Sci Statements 2002 19 1 46
4. Prevalence of hepatitis C virus in the Mexican population: a systematic review. G Santos-Lopez F Sosa-Jurado V Vallejo-Ruiz D Melendez-Mena J Reyes-Leyva, J Infect 2008 56 281 290 10.1016/j.jinf.2008.02.001 18343505
5. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. F Sosa-Jurado G Santos-Lopez B Guzman-Flores JI Ruiz-Conde D Melendez-Mena MT Vargas-Maldonado Y Martinez-Laguna L Contreras-Mioni V Vallejo-Ruiz J Reyes-Leyva, Virol J 2010 7 18 10.1186/1743-422X-7-18 20100349
6. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Goncales Jr D Häussinger M Diago G Carosi D Dhumeaux A Craxi A Lin J Hoffman J Yu, N Engl J Med 2002 347 975 982 10.1056/NEJMoa020047 12324553
7. How cells respond to interferons. GR Stark IM Kerr BR Williams RH Silverman RD Schreiber, Annu Rev Biochem 1998 67 227 264 10.1146/annurev. biochem.67.1.227 9759489
8. Predictors of a favorable response to alpha interferon therapy for hepatitis C. E Barnes G Webster S Whalley G Dusheiko, Clin Liver Dis 1999 3 775 791 10.1016/S1089-3261(05)70238-5 11291250
9. The molecular basis for responsiveness to anti-viral therapy in hepatitis C. SJ Polyak M Gerotto, Forum (Genova) 2000 10 46 58 10717257
10. Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. JQ Han DJ Barton, RNA 2002 8 512 525 10.1017/S1355838202020617 11991644
11. Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Y Castelruiz E Larrea P Boya MP Civeira J Prieto, Hepatology 1999 29 1900 1904 10.1002/hep.510290625 10347136
12. Hepatitis C virus and interferon resistance. DR Taylor ST Shi MM Lai, Microbes Infect 2000 2 1743 1756 10.1016/S1286-4579(00)01329-0 11137047
13. Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. E Mizukoshi S Kaneko K Kaji S Terasaki E Matsushita M Muraguchi Y Ohmoto K Kobayashi, Hepatology 1999 30 1325 1331 10.1002/hep.510300516 10534358
14. Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy. R Fukuda N Ishimura S Ishihara A Tokuda S Satoh S Sakai S Akagi M Watanabe S Fukumoto, J Gastroenterol 1996 31 806 811 10.1007/BF02358606 9027643
15. Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases. N Ishimura R Fukuda S Fukumoto, J Gastroenterol Hepatol 1996 11 712 717 10.1111/j.1440-1746.1996.tb00319.x 8872766 (Pubitemid 26252899)
16. Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients. Y Yamaguchi K Hino D Fujiwara F Ren Y Katoh Y Satoh K Okita, Dig Dis Sci 2002 47 1611 1617 10.1023/A:1015887723557 12141824
17. HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. KG Frey CM Ahmed R Dabelic LD Jager EN Noon-Song SM Haider HM Johnson NJ Bigley, J Immunol 2009 183 1253 1262 10.4049/jimmunol.0900570 19542368
18. Inhibitors of cytokine signal transduction. S Wormald DJ Hilton, J Biol Chem 2004 279 821 824 10.1074/jbc.R300030200 14607831
19. SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. S Brand K Zitzmann J Dambacher F Beigel T Olszak G Vlotides ST Eichhorst B Goke H Diepolder CJ Auernhammer, Biochem Biophys Res Commun 2005 331 543 548 10.1016/j.bbrc.2005.04. 004 15850793
20. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. H Miyoshi H Fujie Y Shintani T Tsutsumi S Shinzawa M Makuuchi N Kokudo Y Matsuura T Suzuki T Miyamura K Moriya K Koike, J Hepatol 2005 43 757 763 10.1016/j.jhep.2005.03.028 16083990
21. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. H Yoshikawa K Matsubara GS Qian P Jackson JD Groopman JE Manning CC Harris JG Herman, Nat Genet 2001 28 29 35 10.1038/88225 11326271
22. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. R Fukuda N Ishimura Y Kushiyama N Moriyama S Ishihara S Nagasawa T Miyake M Niigaki S Satoh S Sakai S Acagi M Watanabe S Fukumoto, J Hepatol 1997 26 455 461 10.1016/S0168-8278(97)80407-2 9075649
23. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C. KB Massirer MH Hirata AE Silva ML Ferraz NY Nguyen RD Hirata, Braz J Med Biol Res 2004 37 643 647 10.1590/S0100- 879X2004000500003 15107924
24. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. AG Jegalian H Wu, J Biol Chem 2002 277 2345 2352 10.1074/jbc.M105575200 11696536
25. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN- H Saito Y Morita M Fujimoto M Narazaki T Naka T Kishimoto, J Immunol 2000 164 5833 5843 10820262
26. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. T Yoshida H Ogata M Kamio A Joo H Shiraishi Y Tokunaga M Sata H Nagai A Yoshimura, J Exp Med 2004 199 1701 1707 10.1084/jem.20031675 15197228
27. The tumor suppressor activity of SOCS-1. R Rottapel S Ilangumaran C Neale J La Rose JM Ho MH Nguyen D Barber P Dubreuil P de Sepulveda, Oncogene 2002 21 4351 4362 10.1038/sj.onc.1205537 12080466
28. Knocking the SOCS off a tumor suppressor. T Kishimoto H Kikutani, Nat Genet 2001 28 4 5 10.1038/88244 11326261
29. Regulation of cytokine receptor signaling by SOCS1. S Ilangumaran R Rottapel, Immunol Rev 2003 192 196 211 10.1034/j.1600-065X.2003.00020.x 12670405
30. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609
31. Analyzing real-time PCR data by the comparative C(T) method. TD Schmittgen KJ Livak, Nat Protoc 2008 3 1101 1108 10.1038/nprot.2008.73 18546601